Skip to Main Content

Paper Details

Effect of SGLT2 Inhibitors on Cardiovascular Outcomes Across Various Patient Populations.
J Am Coll Cardiol
20
2023
CKD, CV, CV death, HF, HFH, Patient, SGLT2, T2DM, cardiovascular (CV) death, chronic kidney disease, glucose, heart failure, patient, patients, sodium-, sodium-glucose cotransporter-2, type 2 diabetes mellitus
Author NameAffiliation
Gerasimos FilippatosAttikon University Hospital, National and Kapodistrian University of Athens
Gregg C FonarowUniversity of California Los Angeles
Gregg C FonarowUniversity of California Los Angeles
Mikhail KosiborodSaint Luke's Mid America Heart Institute, University of Missouri Kansas City
Ileana L Pi??aThomas Jefferson University
  • 1 - 5

Datasets

Release 1.2